The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is also frequently assessed, since the MGMT status in glioblastoma is both predictive of the response to chemotherapy and an independent prognostic variable [5]. The gene discussed is MGMT; the disease is glioblastoma.